New Mexico Register / Volume XXXVII,
Issue 16 / August 25, 2026
This
is an amendment to 16.8.7 NMAC, Section 15, effective 08/31/2026.
16.8.7.15 REQUIRED
TESTING OF CANNABIS PRODUCTS: A cannabis
establishment shall segregate a batch of cannabis product and arrange for
samples to be collected and tested by a cannabis testing laboratory if required
by this section. The batch must pass all required tests prior to the sale or
delivery to another licensee, a qualified patient, primary caregiver or
consumer.
A. Required testing for cannabis producers: Unless
an exception applies:
(1) A
cannabis producer, cannabis producer microbusiness, vertically integrated
cannabis establishment, or integrated cannabis microbusiness shall arrange for
and pay for the testing specified in Table 1, Required Testing of Cannabis
Products, below, of any cannabis flower and trim that it harvests prior to:
(a) packaging
for retail sale;
(b) transfer
to another cannabis establishment for the purposes of retail sale;
(c) retail
sale; or
(d) delivery
to a patient or consumer.
(2) A cannabis
manufacturer, vertically integrated cannabis establishment, or integrated
cannabis microbusiness shall arrange for and pay for the testing specified in
Table 1 of any cannabis product, including but not limited to a concentrate or
extract, that it manufactures prior to:
(a) packaging
for retail sale
(b) transfer
to another cannabis establishment for the purposes or retail sale;
(c) retail
sale; or
(d) delivery
to a qualified patient, primary caregiver or consumer.
(3) A
cannabis retailer, cannabis consumption lounge, vertically integrated cannabis
establishment, or integrated cannabis microbusiness shall not sell or deliver
to a patient or consumer any cannabis product unless the cannabis product has [undergone
all testing required by this section]:
(a) undergone all testing specified in Table 1, Required Testing of Cannabis and
Cannabis
Products below, and
(b) the licensee has confirmed that the
cannabis or cannabis product has a
certificate
of analysis issued by a cannabis testing laboratory licensed by the division
demonstrating that the product meets all applicable testing requirements.
|
Table 1, Required Testing of Cannabis
Products |
||||||
|
Product category |
Potency |
|
Visual Inspection |
Microbiological |
Residual Pesticides |
Residual Solvents |
|
Audited
Product |
X |
|
X |
X |
X |
X |
|
Concentrate
(CO2) |
X |
|
X |
X |
X |
|
|
Concentrate
(non-volatile solvent) e.g. mechanical extraction |
X |
|
X |
X |
X |
|
|
Concentrate (volatile solvent) e.g. Butane, Propane, Ethanol |
X |
|
X |
X |
X |
X |
|
Flower |
X |
|
X |
X |
X |
|
|
Infused
Cannabis Materials (CO2) |
X |
|
X |
X |
X |
|
|
Infused
Cannabis Materials (non-volatile solvent) |
X |
|
X |
X |
X |
|
|
Infused
Cannabis Materials (volatile solvent) |
X |
|
X |
X |
X |
X |
|
Infused-pre-roll
(CO2) |
X |
|
X |
X |
X |
|
|
Infused-pre-roll
(non-volatile solvent) |
X |
|
X |
X |
X |
|
|
Infused-pre-roll
(volatile solvent) |
X |
|
X |
X |
X |
X |
|
Oral
Consumption e.g. strips, lozenges, edibles |
X |
|
X |
X |
X |
X |
|
Other
Inhalable (concentrate with added ingredients) |
X |
|
X |
X |
[ |
X |
|
Pre-roll |
X |
|
X |
X |
X |
|
|
Tincture
(concentrate added to alcohol) |
X |
|
X |
X |
X |
X |
|
Topical |
X |
|
X |
X |
X |
X |
|
Trim |
X |
|
X |
X |
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[*Pesticide testing required
unless exempted by Subsection E, below.]
B. Staggered implementation:
(1) The
division may within its discretion
delay implementation of sample collection and testing requirements of this
section, in whole or in part.
(2) In
determining the start date of an individual testing requirement, the division
shall consider whether a cannabis testing laboratory has validated a method for
conducting the test.
(3) In determining the date on which a cannabis establishment
must have its samples collected by an employee or contractor of a cannabis
testing laboratory, the division shall consider the capacity of cannabis
testing laboratories to collect and transport samples.
(4) The division may establish different implementation dates
for sample collection requirements for:
(a) cannabis producer microbusinesses and integrated cannabis
microbusinesses located up to 100 miles by automobile from the nearest licensed
cannabis testing laboratory location;
(b) cannabis producers, cannabis manufacturers, and vertically
integrated cannabis establishments located up to 200 miles by automobile from
the nearest licensed cannabis testing laboratory location;
(c) cannabis producer microbusinesses and integrated cannabis
microbusinesses located more than 100 miles by automobile from the nearest
licensed cannabis testing laboratory location;
(d) cannabis
producers, cannabis manufacturers, and vertically integrated cannabis
establishments located more than 200 miles by automobile from the nearest
licensed cannabis testing laboratory location; and
(e) cannabis establishments for which travel to a licensed
cannabis testing laboratory location requires passing through a United States
border patrol checkpoint.
C. Collection and transportation of
samples: A
cannabis testing laboratory is responsible for the collection of samples for
the performance of any required test, re-test after a failing result, re-test
after remediation, or test for the purposes of labeling.
(1) A
cannabis testing laboratory may perform sample collection using:
(a) Laboratory
employees with requisite training, as specified in 16.8.2.26 NMAC; or
(b) Contractors
who have completed the sampling agent training offered by the U.S. department
of agriculture’s domestic hemp production program and sign an affidavit that
they have no ownership interest in, and are not employed by, any cannabis
establishment that produces or manufactures cannabis. The contractor shall
obtain necessary training to comply with the cannabis testing laboratory’s
protocols, and the cannabis testing laboratory may reject any sample that it
suspects was collected outside of its protocols.
(2) A
cannabis testing laboratory may transport samples using:
(a) Laboratory
employees with requisite training, as specified in 16.8.2.26 NMAC; or
(b) Contractors
who sign an affidavit that they have no ownership interest in, and are not
employed by, any cannabis establishment that produces or manufactures cannabis.
Transporting cannabis for a cannabis establishment on a contractual basis does
not preclude a person or entity from transporting samples in secure containers
for cannabis testing laboratories.
(3) Nothing
in these rules shall be interpreted to require a cannabis testing laboratory to
collect samples from or transport samples on behalf of any cannabis
establishment.
(4) If
the division has delayed implementation of the requirement that the cannabis
testing laboratory collect the sample from a cannabis establishment, based on
its distance from the nearest cannabis testing laboratory or location beyond a
U.S. border patrol checkpoint, then any person collecting or transporting
samples for required testing must receive training in sample collection and
transportation protocols.
(a) Nothing
in these rules shall be interpreted to require a cannabis testing laboratory to
accept samples from a cannabis establishment.
(b) The
cannabis testing laboratory may reject any sample that it suspects was
collected outside of its protocols.
(5) A
cannabis establishment may specify reasonable precautions prevent the
contamination of batches of cannabis, except that the cannabis establishment
must provide access to the entire batch of cannabis product. Precautions may
include, but are not limited to:
(a) requiring the use of gloves and
other personal protective equipment;
(b) inspecting
tools and containers prior to their use;
(c) specifying
the location within the cannabis establishment at which the samples will be
collected;
(d) specifying
locations within the cannabis establishment to which laboratory employees or
contractors do not have access; and
(e) the
right to refuse entry to any laboratory employee or contractor not in
compliance with the precautions
(6) Nothing in these
rules shall be interpreted to require routine testing of cannabis products
before the cannabis establishment segregates cannabis products into batches and
places the batches into containers for storage while awaiting test results.
(7) This Subsection C of 16.8.7.8 NMAC is
effective March 1, 2023.
D. Compliance with all rules and applicable laws required:
Passage of testing does not relieve an establishment of its obligation to
comply with the Cannabis Regulation Act, the Lynn and Erin Compassionate Use
Act, the Pesticide Control Act, division rules, or other local, state, and
federal laws not in conflict with the Cannabis Regulation Act or the Lynn and
Erin Compassionate Use Act.
(1) A
cannabis establishment shall waste and dispose of any cannabis product to which
a pesticide has been applied in violation of division rules or the Pesticide
Control Act or any product manufactured using an unapproved solvent.
(2) Nothing
in this rule shall be interpreted as precluding regulatory activities by other
state agencies that do not conflict with the Cannabis Regulation Act or the
Lynn and Erin Compassionate Use Act.
E. Exceptions to required testing:
[(1) A cannabis establishment shall not be required to have tested for
pesticide residue any cannabis product made from cannabis concentrate or
cannabis extract with verified pesticide residue test results, so long as the
establishment can demonstrate that the resulting product will not exceed action
levels for that type of cannabis product.
(2)] (1) A cannabis establishment
shall not be required to have tested a cannabis product acquired from another
cannabis establishment if the batch, in present form, was previously determined to have passed the testing requirements of this rule
and is accompanied by a Certificate of
Analysis issued by a licensed cannabis testing laboratory within the
previous 90 days.
[(3)] (2) If
additional testing requirements take effect after a cannabis testing laboratory
obtains a sample of a cannabis product for required testing,
the laboratory is required to perform only those tests required at the time the
sample was obtained.
F. Visual inspection: A sample shall pass visual inspection if,
under a minimum of 40X magnification, laboratory personnel detect in a one gram
sample:
(1) no living or dead insects, hair,
eggs, or feces; and
(2) no more than two percent sand,
soil, mold, or rocks.
G. Microbiological testing: A sample shall
pass microbiological testing if the sample contains concentrations of target
microbes not exceeding the action levels set forth in Table 2, Microbiological
Testing Requirements, below.
(1) The
division may require required testing for additional microbes if quality
control or inspection testing conducted by cannabis testing laboratories, NMDA,
the department of health, or the division identifies their presence, in a
quantity or amount that poses a threat to public health, in a cannabis product
produced, manufactured, or sold by any cannabis establishment. The division
shall provide written notice to licensees 30 days before requiring required
testing for additional pesticide residues, except that such notice is not
required when human illness is linked to contaminated cannabis products.
(2) The
cannabis testing laboratory may report a collective total of the four
Aspergillus strains listed without distinguishing individual totals.
(3) The
test results shall be reported as “Present,” “Absent,” or in colony forming
units (CFU) per one gram sample.
(4) Testing for shiga-toxin
producing E. coli, Clostridium botulinum, and Pseudomonas aeruginosa is
effective July 1, 2022.
|
Table 2. Microbiological Testing
Requirements |
|
|
Target Microbe |
Action Level |
|
*E. coli |
100 CFU/gram |
|
Aspergillus flavus, Aspergillus fumigatus, Aspergillus niger,
or Aspergillus terreus |
Present in 1 gram |
|
Salmonella spp. |
Present in 1 gram |
|
†Shiga-toxin producing E. coli |
Present in 1 gram |
|
†Clostridium botulinum |
Present in 1 gram |
|
†Pseudomonas aeruginosa |
Present in 1 gram |
|
*Cannabis product may be tested
for shiga-toxin producing E. coli, rather than
generic E. coli. †Testing for shiga-toxin
producing E. coli, Clostridium botulinum, and Pseudomonas aeruginosa is
required only for edible cannabis products manufactured from fresh cannabis
with a water activity of 0.65 or greater. |
|
H. Residual solvent testing: A sample shall pass residual
solvent testing if the sample contains concentrations of residual solvents
lower than the action levels set forth in Table 3, Residual Solvent Testing
Requirements, below. The test results shall be reported as described in the
notes to Table 3.
Table 3. Residual Solvent Testing
Requirements |
|||||
|
Target Compounds |
Common Chemical Name |
IUPAC
Name |
CAS Number |
Action Level* |
|
|
Propane |
Propane |
Propane |
74-98-6 |
5000 |
|
|
Butanes |
n-butane |
Butane |
106-97-8 |
5000 |
|
|
Isobutane |
2-methylpropane |
75-28-5 |
5000 |
|
|
|
Pentane |
n-pentane |
Pentane |
109-66-0 |
5000 |
|
|
Hexane |
n-hexane |
Hexane |
110-54-3 |
290 |
|
|
Benzene |
Benzene |
Benzene |
71-43-2 |
2.0 |
|
|
Toluene |
Toluene |
Methylbenzene |
108-88-3 |
890 |
|
|
Heptane |
n-heptane |
Heptane |
142-82-5 |
5000 |
|
|
Ethylbenzene and
Xylenes |
Ethylbenzene |
Ethylbenzene |
100-41-4 |
2170 Total |
|
|
ortho-xylene |
1,2-dimethylbenzene |
95-47-6 |
|
||
|
meta-xylene |
1,3-dimethylbenzene |
108-38-3 |
|
||
|
para-xylene |
1,4-dimethylbenzene |
106-42-3 |
|
||
|
Ethanol† |
ethyl alcohol |
Ethanol |
64-17-5 |
5000 |
|
|
Methanol |
methyl alcohol |
Methanol |
67-56-1 |
3000 |
|
|
Isopropanol |
Isopropyl alcohol |
2-propanol |
67-63-0 |
5000 |
|
|
Acetone |
Acetone |
2-propanone |
67-64-1 |
5000 |
|
|
Use
two significant digits when reporting residual solvent results. Report
levels less than the Limit of Quantitation for each solvent according to the
following example:: "Benzene < 2.0
µg/g" *Micrograms
solvent per gram (µg/g) of sample/parts per million (ppm). †Unless
exempt from testing. |
|||||
I. Potency testing: Potency testing requires
determining the quantity of tetrahydrocannabinol (THC), tetrahydrocannabinolic
acid (THCA), cannabidiol (CBD), cannabidiolic acid
(CBDA) per gram of sample and the calculation of THC potency and CBD potency,
according to Table 4, Potency Testing Requirements, below.
|
Table 4. Potency Testing Requirements |
|||
|
Cannabinoid |
Abbreviation |
CAS
Number |
Reporting
Units |
|
Tetrahydrocannabinolic Acid |
THCA |
23978-85-0 |
For solids: mg of analyte/gram
of sample and percentage by weight For liquids: mg/ml |
|
Tetrahydrocannabinol |
THC |
1972-08-3 |
|
|
Cannabidiolic Acid |
CBDA |
1244-58-2 |
|
|
Cannabidiol |
CBD |
13956-29-1 |
|
|
Total
THC Potency (solids) |
THC Potency = (Percent THCA ×
0.877) + Percent THC |
Percentage by weight |
|
|
Total
CBD Potency (solids) |
CBD Potency = (Percent CBDA ×
0.877) + Percent CBD |
||
|
Total
THC Potency (liquids) |
THC Potency = (mg/ml THCA ×
0.877) + mg/ml THC |
mg/ml |
|
|
Total
CBD Potency (liquids) |
CBD Potency = (mg/ml CBDA ×
0.877) + mg/ml CBD |
||
J. Pesticide
testing: A sample shall pass pesticide testing if
concentrations of residues of pesticides are lower than the action levels
listed in Table 5, Pesticide Testing Requirements, below.
(1) The
division may adopt required testing for additional pesticide residues if
quality control or inspection testing conducted by cannabis testing
laboratories, NMDA, the department of health, or the division identifies their
presence in a cannabis product produced or manufactured by any cannabis
establishment. The division shall provide written notice to licensees 30 days
before implementing required testing for additional pesticide residues.
(2) Nothing
in this section shall be interpreted to waive or diminish any requirement of
the Pesticide Control Act, Sections 76-4-1 et seq. NMSA 1978. The division, alone or in conjunction with
NMDA, may investigate any suspected use of a pesticide not registered with NMDA
for use on cannabis.
(3) This Subsection J of 16.8.7.8 NMAC is
effective July 1, 2022.
|
Table 5. Pesticide Testing Requirements |
|||
|
Targeted
Pesticide |
CAS
Number |
Action Level: Inhalable* |
Action Level:
Non-Inhalable* |
|
†Abamectin |
71751-41-2 |
0.1 |
0.15 |
|
†Acequinocyl |
57960-19-7 |
2.0 |
2.0 |
|
†Bifenazate |
149877-41-8 |
0.2 |
0.2 |
|
†Bifenthrin |
82657-04-3 |
0.1 |
0.1 |
|
†Etoxazole |
153233-91-1 |
0.1 |
1.0 |
|
†Imazalil |
35554-44-0 |
0.1 |
0.1 |
|
†Imidacloprid |
138261-41-3 |
0.1 |
3.0 |
|
†Myclobutanil |
88671-89-0 |
0.1 |
0.4 |
|
†Paclobutrazol |
76738-62-0 |
0.04 |
0.04 |
|
Piperonyl
butoxide |
51-03-6 |
3.0 |
8.0 |
|
†Pyrethrins
(cumulative
total) |
121-21-1 25402-06-6 4466-14-2 |
0.5 |
1.0 |
|
†Spinosyn A, D (cumulative total) |
131929-60-7 131929-63-0 |
0.1 |
3.0 |
|
†Spiromesifen |
283594-90-1 |
0.1 |
0.2 |
|
†Spirotetramat |
203313-25-1 |
0.1 |
0.2 |
|
†Trifloxystrobin |
141517-21-7 |
0.02 |
0.02 |
|
Other
pesticide not registered with NMDA for use on cannabis |
Varies |
0.02 |
0.02 |
|
*Micrograms
of pesticide per gram (µg/g) of
sample/parts per million (ppm). Report
levels less than the Limit of Quantitation for each pesticide residue
according to the following example: "Paclobitrazol < 0.4 µg/g" †Not
registered with NMDA for use on cannabis. |
|||
K. Release of batch after testing: A cannabis establishment may
release an entire batch of cannabis product for immediate manufacture, sale, or other use, provided that the
sample taken from the batch passes the tests required in this section.
L. Procedures for testing: A cannabis establishment shall adhere to
the following procedures:
(1) After
collection of samples, a batch of cannabis product shall be segregated in a
secure container and stored under controlled environmental conditions
(temperature, humidity, light) designed to limit microbial growth or other
spoilage until the cannabis establishment receives a certificate of analysis
indicating the batch meets the testing requirements of this rule.
(2) The
secured container shall be labeled with the identification number used in the track
and trace system, the name of the cannabis testing laboratory, the date on
which the samples were taken, and, in minimum 12-point font, all capital
letters, “AWAITING TEST RESULTS. DO NOT TRANSFER.”
(3) The
cannabis testing laboratory and the cannabis establishment submitting samples
each shall appropriately document in the track and trace system the sampling
and testing of cannabis product.
(4) A
cannabis establishment shall maintain all results of laboratory tests conducted
on cannabis products produced or manufactured by the cannabis establishment for
a period of at least two years and shall make those results available to
consumers or cannabis retailers upon request.
M. Re-testing: If a sample fails any
test, the cannabis establishment may request re-testing by the same cannabis
testing laboratory or another cannabis testing laboratory. If the repeated test
is within acceptable limits, then the batch may be sold, transferred, or further
manufactured.
N. Remediation:
Within 120 days of a failed test, a cannabis establishment may remediate
and retest the batch according to the procedures described in this subsection.
A cannabis establishment shall adopt and maintain on the premises protocols
regarding remediation consistent with this rule.
(1) A
cannabis establishment may remediate dried cannabis or cannabis concentrates
that fail microbiological testing by means of extraction using an approved
volatile solvent. Other products that fail microbiological testing may not be
remediated.
(2) A
cannabis establishment may remediate any cannabis product that fails
homogeneity testing through any approved manufacturing process, including
extraction, chopping, melting, mixing, infusing, or otherwise combining the
batch.
(3) A
cannabis establishment may remediate any cannabis product that fails residual
solvent testing by evaporating solvent using heat, vacuum pressure, or a
combination of methods.
(4) A
cannabis establishment may remediate cannabis that fails visual inspection for
the presence of mold by means of extraction using an approved volatile solvent.
(5) A
cannabis establishment may remediate cannabis that fails visual inspection for
the presence of insects, hair, eggs, or feces by removing the contaminants,
followed by extraction using an approved volatile solvent.
(6) A
cannabis establishment may remediate cannabis that fails visual inspection for
the presence of soil or rocks by removing the contaminants.
(7) Cannabis
product that has been remediated must undergo any test that was previously
failed.
(8) Cannabis
product that has been remediated with the use of volatile solvents must
additionally undergo residual solvent testing.
O. Notice
and destruction: Any cannabis
product that fails a test and cannot be remediated, including any
remediated cannabis product that fails any test after remediation or any
cannabis product that fails a test for pesticides pursuant to the New Mexico
Pesticide Control Act, Section 76-4-1 et seq., NMSA 1978, is subject
to destruction in accordance with the wastage requirements of 16.8.2.15 NMAC.
The cannabis establishment shall notify the division within 24 hours and shall
confirm the wastage and disposal of the usable cannabis in accordance with this
rule. The wasted product shall be removed from inventory, and the removal from
inventory shall be noted in the track and trace system.
P. Interpretation of differing results: Results produced by a cannabis testing laboratory
are valid only for the sample tested. A differing result produced by quality
control or inspection testing of a different sample pursuant to 16.8.2.16 NMAC
is not grounds for action against the cannabis testing laboratory that produced
the original testing result.
[16.8.7.15
NMAC – N, 07/12/2022; A/E, 11/18/2022; A, 08/31/2026]